Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00527891 · ClinicalTrials.gov registry record
Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 16
- Enrollment target
NCT00527891: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00527891 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00527891 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Primary Objective: 1\. To compare the efficacy of 1.5T vs. 3T T1 and T2-weighted MR images sequences for the detection and evaluation of liver lesions.
Interventions
- PROCEDURE Signa Excite 3.0 T MRI Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2004-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00527891
The ClinicalTrials.gov registry entry for NCT00527891 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Signa Excite 3.0 T MRI Scan is the first listed.
NCT00527891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00527891 about?
NCT00527891 is a clinical study titled "Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions". Primary Objective: 1\. To compare the efficacy of 1.5T vs. 3T T1 and T2-weighted MR images sequences for the detection and evaluation of liver lesions.
What is the current status of trial NCT00527891?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2004-06.
What interventions are being tested in trial NCT00527891?
The interventions under investigation include: Signa Excite 3.0 T MRI Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00527891?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.